MX2007007099A - Implante formado in situ para animales. - Google Patents

Implante formado in situ para animales.

Info

Publication number
MX2007007099A
MX2007007099A MX2007007099A MX2007007099A MX2007007099A MX 2007007099 A MX2007007099 A MX 2007007099A MX 2007007099 A MX2007007099 A MX 2007007099A MX 2007007099 A MX2007007099 A MX 2007007099A MX 2007007099 A MX2007007099 A MX 2007007099A
Authority
MX
Mexico
Prior art keywords
animals
situ forming
forming implant
implant
administered
Prior art date
Application number
MX2007007099A
Other languages
English (en)
Inventor
Ute Isele
Caroline Sautter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2007007099A publication Critical patent/MX2007007099A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se refiere a una composicion, que comprende un polimero termoplastico, un agente modificador de velocidad y un agente biologicamente activo, util como un implante de administracion de medicamento de liberacion retardada en el cuerpo de un humano o animal, que puede administrarse en forma liquida en el cuerpo.
MX2007007099A 2004-12-14 2005-12-13 Implante formado in situ para animales. MX2007007099A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14
PCT/EP2005/013377 WO2006063794A1 (en) 2004-12-14 2005-12-13 In-situ forming implant for animals

Publications (1)

Publication Number Publication Date
MX2007007099A true MX2007007099A (es) 2007-06-22

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007099A MX2007007099A (es) 2004-12-14 2005-12-13 Implante formado in situ para animales.

Country Status (16)

Country Link
JP (1) JP5372378B2 (es)
KR (1) KR101304160B1 (es)
CN (1) CN101056617B (es)
AR (1) AR052155A1 (es)
AT (1) ATE389386T1 (es)
AU (1) AU2005315823B2 (es)
BR (1) BRPI0519022A2 (es)
CA (1) CA2585779C (es)
DE (1) DE602005005522T2 (es)
ES (1) ES2301084T3 (es)
MX (1) MX2007007099A (es)
NZ (1) NZ554904A (es)
RU (1) RU2394558C2 (es)
TW (1) TWI369218B (es)
WO (1) WO2006063794A1 (es)
ZA (1) ZA200703506B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
MX354603B (es) 2007-05-25 2018-03-13 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
CN101159064B (zh) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 画像生成系统以及按照图像生成画像的方法
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 眼内薬物送達デバイスおよび付随する方法
EP3609470B1 (en) * 2017-04-13 2023-11-22 Ceva Santé Animale Implant for treating parasites infestations
CN112336682B (zh) * 2020-09-28 2022-07-08 浙江大学 具有缓控释药物作用的可注射复合载体与组合物及制备方法
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
CA2275587C (en) * 1996-12-20 2006-10-24 Alza Corporation Injectable depot gel composition and method of preparing the composition
WO1999047073A1 (en) * 1998-03-19 1999-09-23 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (ja) * 1998-09-18 2009-08-19 サンスター株式会社 固体粒子形成用組成物
US7368126B2 (en) * 2002-11-06 2008-05-06 Guohua Chen Controlled release depot formulations
JP2007525429A (ja) * 2003-03-11 2007-09-06 キューエルティー ユーエスエー，インコーポレイテッド． 細胞スケジュール依存性抗癌剤のための処方

Also Published As

Publication number Publication date
DE602005005522T2 (de) 2009-04-16
CA2585779C (en) 2014-01-28
AR052155A1 (es) 2007-03-07
NZ554904A (en) 2009-11-27
TW200635616A (en) 2006-10-16
DE602005005522D1 (de) 2008-04-30
BRPI0519022A2 (pt) 2008-12-23
WO2006063794A1 (en) 2006-06-22
RU2394558C2 (ru) 2010-07-20
JP5372378B2 (ja) 2013-12-18
JP2008523131A (ja) 2008-07-03
ES2301084T3 (es) 2008-06-16
KR101304160B1 (ko) 2013-09-04
CN101056617B (zh) 2012-07-11
ATE389386T1 (de) 2008-04-15
RU2007126759A (ru) 2009-01-27
CA2585779A1 (en) 2006-06-22
KR20070092964A (ko) 2007-09-14
AU2005315823B2 (en) 2009-06-04
AU2005315823A1 (en) 2006-06-22
TWI369218B (en) 2012-08-01
ZA200703506B (en) 2008-09-25
CN101056617A (zh) 2007-10-17

Similar Documents

Publication Publication Date Title
MX2007007099A (es) Implante formado in situ para animales.
WO2007038246A3 (en) Solid polymer delivery compositions and methods for use thereof
WO2006023130A3 (en) Biodegradable controlled release bioactive agent delivery device
SI2561860T1 (en) An implantable polymeric device for prolonged release of buprenorphine
MX2007006214A (es) Un implante para suministro de farmaco intraocular.
WO2005013936A3 (en) Manufacture of long term drug delivery devices with polyurethane based polymers
EP2407203A3 (en) Solid therapeutic agent for use in an implantable drug delivery device
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
WO2006002366A3 (en) Biodegradable ocular devices, methods and systems
EA200600484A1 (ru) Доставка физиологических агентов in situ при помощи гелей, включающих анионные полисахариды
WO2006079055A3 (en) Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues
MY167123A (en) Conveniently implantable sustained release drug compositions
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
WO2009029958A3 (en) Implantable delivery device
TW200630128A (en) Active ingredient-containing silicone elastomers
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
GB2443793B (en) Product, method of manufacture and use
WO2008020931A3 (en) Device for delivery of anti-cancer agents to tissue
ATE505508T1 (de) Arzneistoffzufuhrvorrichtung, die einen wirkstoff enthält, und verfahren zur freisetzung eines wirkstoffs aus einer arzneistoffzufuhrvorrichtung
WO2004110400A3 (en) Implantable polymeric device for sustained release of nalmefene
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
MX2009001231A (es) Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.
WO2009148579A3 (en) Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient

Legal Events

Date Code Title Description
FG Grant or registration
HH Correction or change in general